Clinical trial · Interventional
Percutaneous Thermal Ablation in Lung Tumors
Percutaneous Thermal Ablation in Treatment of Lung Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Lung cancer has a high incidence globally, with Egypt having it as the third most common and most lethal cancer, affecting 16.9% of males and 3.8% of females. While surgery is the preferred treatment for stage 1 non-small cell lung cancer due to positive outcomes, it carries significant risks due to patient comorbidities. Non-invasive treatments like radio frequency ablation (RFA) and microwave ablation (MWA) are alternatives for those unable to undergo surgery. These techniques use energy to destroy tumor tissue with minimal invasiveness and can be guided by computed tomography to ensure accurate ablation.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Percutaneous thermal ablation of lung tumors | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Patients
- description
- Thermal ablation of lung tumors
- interventionNames
- Radiation: Percutaneous thermal ablation of lung tumors
Primary outcomes (1)
- measure
- Accuracy and success
- timeFrame
- 1 year
- description
- Determination of tumor size in cm after thermal ablation in treatment of patients who are unfit for surgery or have tumors smaller than 5 cm or metastasis to the lung
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * lung cancer smaller than 5 cm * metastasis to the lung * patients with lung cancer and multiple comorbidities who are unfit for surgery Exclusion Criteria: * lung cancer larger than 5 cm * lung cancer stage II or more * patients who cannot tolerate CT guided needle placement for thermal ablation of lung tumors
References
Publications (0)
Data not yet available